First Solar, Inc. to Announce Third Quarter 2026 Financial Results - FIRST SOLAR INC

Explicit Guidance:

• FY2026: Updated revenue and Adjusted EBITDA guidance reduced to reflect lower range of India domestic, India international Series 6, and U.S. finishing volume sold; India domestic volume sold forecast reduced by ~0.7 GW; total FY2026 operating expense guidance unchanged; net cash guidance unchanged ($1.5B–$2.0B range).
• FY2026 R&D: Perovskite-related spend increased from $100M to ~$120M total, primarily driven by the 2027 ramp.
• FY2027 India Output: Finished goods production expected to range from 2.2 GW to 2.6 GW; exports from India to the U.S. expected to increase subject to a supportive trade environment to optimize margin.
• FY2027 U.S. Manufacturing: South Carolina finishing facility second phase expected to reach commercial launch in mid-2027, contributing to 2.2–2.5 GW of total South Carolina production for 2027; Series 7 conversion at India facility expected to begin Q1 2027.
• FY2027 Malaysia: Operating decision (full/near-full capacity of 128 GW annual output vs. shutdown) expected in the first half of 2027; decision unlikely to materially impact run-rate earnings.
• FY2027 Perovskite: Ohio pilot line expected to reach operational readiness in the first half of 2027 for field deployment validation.
• FY2028–2030: Backlog deliveries extend through 2030; ~4 GW of variable volume associated with pre-Section 232 contracts (half with decision date within 5 months, remainder spread through 2027–2028).
• Capital Allocation: Board authorized share repurchase program of up to $500M (immediate, no expiration); net cash target range maintained at $1.5B–$2.0B.

Business-Segment Outlook:

• Technology Transition: Series 7 QR replication across the fleet to commence with India facility conversion in Q1 2027, followed by U.S. Series 7 conversions; India launch intended to refine deployment in a low-earnings impact environment before U.S. replication.
• Manufacturing Flow: Integrated manufacturing flow from Vietnam to South Carolina; India front-end output planned to flex supply U.S. facilities during U.S. Series 7 conversions to preserve partial domestic content/Section 45X eligibility.
• Product Mix & Pricing: Shift toward project-specific contracting with defined schedules to improve pricing ASPs and mitigate delivery risk; pricing expected to vary by product (Series 6 vs. 7), geography (U.S. vs. international), and technology adjuster realization (majority of adjusted value expected in 2027–2028).
• Backlog Composition: 44 GW backlog ($13.5B contracted value); transition from multi-year framework agreements to project-specific contracting to optimize module allocation; ~4.9 GW booked in the U.S. this year at ~35–36 cents/W.

Market and Competitive Outlook:

• Demand Drivers: Continued demand strength from load growth, data center expansions, AI infrastructure, and electrification expected to drive long-term earnings growth; solar plus storage prioritized for speed-to-power and bankability.
• Competitive Positioning: First Solar uniquely positioned as the only fully integrated utility-scale manufacturer without dependency on Chinese polysilicon supply chains; structural shift away from adversaries in supply chains expected to favor U.S.-based, FIAT-free supply.
• Market Dynamics: Customers currently delaying early-stage procurement due to NIMBYism, local government opposition, battery price surges, and inflationary pressures; price discovery ongoing post-Section 232 with anticipated pricing increases for post-announcement deals.
• Pricing Evolution: Average Selling Price (ASP) expected to range from lower-end international finished goods to high-end U.S. domestic Series 7; Series 7 CURE expected to be advantaged against perovskite but slightly disadvantaged (by a few pennies) relative to TopCon depending on geography/bifaciality.

Macro / Industry Outlook:

• Section 232 & Trade: Selection 232 proclamation viewed as a structural shift creating long-term earnings opportunity; U.S. government 100% committed to enforcement against stockpiling/pre-232 imports (400 importers of record, ~60 blocked).
• Regulatory Environment: Uncertainty regarding final FIAT guidance and evolving Section 232 Minimum Import Prices (MIPs) continues to inhibit customer clarity; Commerce enforcement expected to intensify, though risk-taking to bypass rules remains high.
• AI & National Security: U.S. competition in AI and low Earth orbit economy viewed as foundational to national security, requiring secure, affordable power; inability to depend on adversarial nations drives structural demand for U.S. manufacturing.
• Tax Credits: $1.9B government grant receivables expected to be refundable 2–3 months after filing; market for credit sales picked up in late 2026, balancing liquidity needs against discount avoidance.

Strategic Initiatives:

• Capacity Expansion: South Carolina finishing facility Phase 2 delayed one quarter to incorporate CURE, targeting mid-2027 launch; India Series 7 conversion starting Q1 2027 to optimize U.S. fleet replication.
• R&D: Continued investment in perovskite roadmap via Ohio pilot line (H1 2027 readiness) and licensing agreements with Cubic PV and Oxford PV for IP access; increased R&D spend ($120M total for Perovskite).
• Contracting Strategy: Pivot to project-specific contracts with defined delivery schedules to reduce inventory/storage costs and improve working capital efficiency; maintaining optionality for framework agreements with strict structural protections.
• M&A/Investments: Capital allocation priority includes growth, technology deployment, and M&A for complementary/adjacent technologies; share repurchases conditional on policy clarity and booking volume.

Risks and Headwinds to Outlook:

• Regulatory & Trade: Potential for continued evolution of Section 232 tariffs, MIPs, and anti-stockpiling measures; risk of importers successfully bypassing enforcement; final FIAT guidance timeline uncertainty.
• Project Execution: Local community opposition (NIMBYism), state/local moratoriums on data centers, interconnection challenges, and battery price surges delaying project timelines and booking cycles.
• Market Volatility: Price discovery uncertainty for late-2028/2029/2030 demand; risk of customers deferring early-stage procurement until 2029–2030 due to near-term economics and policy clarity.
• Manufacturing Decisions: Binary decision on Malaysia facility (shutdown vs. full capacity) in H1 2027 dependent on trade environment; India output flexibility relies on supportive trade conditions.
• Legal: Ongoing litigation regarding Series 7 initial product launch issues (SWIFT lawsuit); IP infringement disputes regarding TopCon.

Management Tone on the Future:

• Confidence: High confidence in long-term value and structural positioning due to U.S. policy framework and AI-driven load growth; disciplined approach to capital allocation and pricing despite near-term booking moderation.
• Pacing: Deliberate on bookings; no "desperate urgency" to book 2029 volumes currently, preferring to wait for policy clarity (FIAT, 232) and market price discovery.
• Strategic Shift: Transitioning from high-volume framework agreements to higher-value, project-specific deals; confident in ability to improve ASPs and contract structures over the next 12–24 months as pricing stabilizes.
• Risk Tolerance: Willing to endure near-term volume fluctuations (e.g., Malaysia decision, India flexing) to optimize long-term earnings profile and maintain balance sheet resiliency ($1.5B–$2.0B net cash).

Miscellaneous:

• Backlog Value: $13.5B in contracted backlog (exclusive of tech adjusters); ~20% of potential adjusted value associated with 2027 deliveries, remainder weighted to 2028.
• Technology Adjusters: Value roll-off expected as CURE technology embeds into base ASPs; realization subject to milestone achievement and customer delivery schedules.
• Q&A Highlights: No exclusions under Section 232 currently granted; enforcement on pre-232 imports is aggressive but incomplete; customers remain concerned about 48-month safe harbor deadlines (completion by end of 2028).